OxThera
Mats-Olof Wallin is the Deputy CEO since 2020 and CFO since 2020. He holds a BSc from Uppsala University. He is also the Deputy Board Member and
of OxThera Intellectual Property AB. Chairman of the board of Directors and CEO of Mowin Konsult AB. Previous assignments in the last five years, he was the CFO of Karo Pharma AB and Sobi AB.
This person is not in any offices
OxThera
OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.